Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Experimental evidence and clinical implications of Warburg effect in the skeletal muscle of Fabry disease
Jessica Gambardella, Antonella Fiordelisi, Federica Andrea Cerasuolo, et al.
iScience (2023) Vol. 26, Iss. 3, pp. 106074-106074
Open Access | Times Cited: 17

Showing 17 citing articles:

Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer
Javad Alizadeh, Mahboubeh Kavoosi, Navjit Singh, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2195-2195
Open Access | Times Cited: 37
Fabry Disease: Cardiac Implications and Molecular Mechanisms
David Weissman, Jan Dudek, Vasco Sequeira, et al.
Current Heart Failure Reports (2024) Vol. 21, Iss. 2, pp. 81-100
Open Access | Times Cited: 5
Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry’s disease
Natalie Lund, Hartwig Wieboldt, Lutz Fischer, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 4
Norharmane prevents muscle aging via activation of SKN-1/NRF2 stress response pathways
Farida S. Nirmala, Hyunjung Lee, Yejin Cho, et al.
Redox Biology (2025) Vol. 80, pp. 103512-103512
Closed Access
Hemodialysis employing molecular hydrogen (H2) enriched dialysis solution may improve dialysis related fatigue through impact on energy metabolism
Masaaki Nakayama, Kimio Watanabe, Emiko Sato, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Cardiac involvement in Fabry disease: Recent advances, unresolved issues, and unmet needs
Maurizio Pieroni, Chiara Zocchi, Michele Ciabatti
European Heart Journal Supplements (2025) Vol. 27, Iss. Supplement_1, pp. i51-i55
Open Access
Fatigue as hallmark of Fabry disease: role of bioenergetic alterations
Jessica Gambardella, Eleonora Riccio, Antonino Bianco, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Cardiopulmonary determinants of reduced exercise tolerance in Fabry disease
Oriana De Marco, Jessica Gambardella, Antonino Bianco, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Antonella Fiordelisi, Federica Andrea Cerasuolo, Roberta Avvisato, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Signaling through cAMP-Epac1 induces metabolic reprogramming to protect podocytes in glomerulonephritis
Lilia Abbad, Maximin Détrait, Panagiotis Kavvadas, et al.
Kidney International (2024) Vol. 106, Iss. 3, pp. 450-469
Closed Access | Times Cited: 2
How do Physical Activity and Exercise affect Fabry Disease? Exploring a New Opportunity
Federica Baciga, Giacomo Marchi, Federica Caccia, et al.
Kidney & Blood Pressure Research (2024) Vol. 49, Iss. 1, pp. 699-717
Open Access | Times Cited: 2
Infertility in Fabry’s Disease: role of hypoxia and inflammation in determining testicular damage
Luigi Sansone, Federica Barreca, Manuel Belli, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Quercetin conjugated PSC-derived exosomes to inhibit intimal hyperplasia via modulating the ERK, Akt, and NF-κB signaling pathways in the rat carotid artery post balloon injury
Xin Mao, Yaming Du, Rubo Sui, et al.
Nanomedicine Nanotechnology Biology and Medicine (2024) Vol. 61, pp. 102763-102763
Closed Access | Times Cited: 1
The Role of Macrophages in Cardiac Function and Disease
Nella Prevete, Daniela Sorriento
Journal of Molecular Pathology (2023) Vol. 4, Iss. 4, pp. 318-332
Open Access | Times Cited: 3
Low skeletal muscle mass as an early sign in children with fabry disease
Zhihong Lu, Guoping Huang, Ling Yu, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Prevalence of papillary muscle hypertrophy in fabry disease
Tomás F. Cianciulli, María Cristina Saccheri, Mariano Napoli Llobera, et al.
BMC Cardiovascular Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Fabry Disease Biomarkers in Patients Switched From Enzyme-Replacement Therapy to Migalastat Oral Chaperone Therapy
Christiane Auray‐Blais, Paméla Lavoie, Tristan Martineau, et al.
Bioanalysis (2023) Vol. 15, Iss. 23, pp. 1421-1437
Closed Access
Page 1

Scroll to top